ORIC Pharmaceuticals Inc
General ticker "ORIC" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $644.2M
ORIC Pharmaceuticals Inc follows the US Stock Market performance with the rate: 4.6%.
Estimated limits based on current volatility of 4.5%: low 7.61$, high 8.33$
Factors to consider:
- Price in estimated range
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [5.66$, 12.47$]
- 2024-12-30 to 2025-12-30 estimated range: [4.74$, 10.81$]
Financial Metrics affecting the ORIC estimates:
- Negative: Non-GAAP EPS, $ of -1.96 <= 0.10
- Negative: Operating profit margin, % of -100 <= 1.03
- Negative: Operating cash flow per share per price, % of -16.15 <= 2.35
- Negative: negative Net income
- Positive: -0.96 < Investing cash flow per share, $ of -0.84
- Negative: Industry operating cash flow per share per price (median), % of -23.87 <= 3.85
- Positive: Industry inventory ratio change (median), % of 0 <= 0
- Negative: Industry earnings per price (median), % of -26.04 <= 1.31
Short-term ORIC quotes
Long-term ORIC plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $78.87MM | $91.77MM | $110.78MM |
| Operating Income | $-78.87MM | $-91.77MM | $-110.78MM |
| Non-Operating Income | $0.16MM | $2.65MM | $10.08MM |
| R&D Expense | $56.86MM | $61.68MM | $85.17MM |
| Income(Loss) | $-78.72MM | $-89.12MM | $-100.70MM |
| Profit(Loss) | $-78.72MM | $-89.12MM | $-100.70MM |
| Stockholders Equity | $272.98MM | $222.35MM | $224.09MM |
| Assets | $298.64MM | $247.18MM | $252.01MM |
| Operating Cash Flow | $-59.54MM | $-75.14MM | $-85.69MM |
| Capital expenditure | $0.94MM | $2.08MM | $0.85MM |
| Investing Cash Flow | $158.44MM | $-109.25MM | $-43.40MM |
| Financing Cash Flow | $49.13MM | $25.23MM | $85.66MM |
| Earnings Per Share* | $-2.05 | $-2.31 | $-1.96 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.